Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 268

1.

Comparison of the early effects of brimonidine and apraclonidine as topical ocular hypotensive agents.

Maus TL, Nau C, Brubaker RF.

Arch Ophthalmol. 1999 May;117(5):586-91.

PMID:
10326954
2.
3.

Comparison of the efficacy of apraclonidine and brimonidine as aqueous suppressants in humans.

Schadlu R, Maus TL, Nau CB, Brubaker RF.

Arch Ophthalmol. 1998 Nov;116(11):1441-4.

PMID:
9823343
4.

Assessment of ocular hypotensive mechanisms and additivity of antiglaucoma drugs in humans.

Kaufman PF.

Arch Ophthalmol. 1999 May;117(5):673-4. Review. No abstract available.

PMID:
10326968
5.
6.
7.

Effects of brimonidine on aqueous humor dynamics in human eyes.

Toris CB, Gleason ML, Camras CB, Yablonski ME.

Arch Ophthalmol. 1995 Dec;113(12):1514-7.

PMID:
7487618
8.
9.

Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.

Quaranta L, Gandolfo F, Turano R, Rovida F, Pizzolante T, Musig A, Gandolfo E.

Invest Ophthalmol Vis Sci. 2006 Jul;47(7):2917-23.

PMID:
16799034
10.

Apraclonidine and timolol. Combined effects in previously untreated normal subjects.

Koskela T, Brubaker RF.

Arch Ophthalmol. 1991 Jun;109(6):804-6.

PMID:
1675048
11.

Effects of apraclonidine on aqueous humor dynamics in human eyes.

Toris CB, Tafoya ME, Camras CB, Yablonski ME.

Ophthalmology. 1995 Mar;102(3):456-61.

PMID:
7891985
13.

The cardiovascular, pulmonary, and ocular hypotensive effects of 0.2% brimonidine.

Nordlund JR, Pasquale LR, Robin AL, Rudikoff MT, Ordman J, Chen KS, Walt J.

Arch Ophthalmol. 1995 Jan;113(1):77-83.

PMID:
7826297
14.

Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology in normal and sympathectomized monkeys.

Gabelt BT, Robinson JC, Hubbard WC, Peterson CM, Debink N, Wadhwa A, Kaufman PL.

Exp Eye Res. 1994 Dec;59(6):633-44.

PMID:
7698258
15.

A 90-day study of the efficacy and side effects of 0.25% and 0.5% apraclonidine vs 0.5% timolol. Apraclonidine Primary Therapy Study Group.

Stewart WC, Laibovitz R, Horwitz B, Stewart RH, Ritch R, Kottler M.

Arch Ophthalmol. 1996 Aug;114(8):938-42.

PMID:
8694728
16.
17.
18.

Brimonidine 0.2% versus apraclonidine 0.5% for prevention of intraocular pressure elevations after anterior segment laser surgery.

Chen TC, Ang RT, Grosskreutz CL, Pasquale LR, Fan JT.

Ophthalmology. 2001 Jun;108(6):1033-8.

PMID:
11382625
20.

Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.

Stewart WC, Konstas AG, Nelson LA, Kruft B.

Ophthalmology. 2008 Jul;115(7):1117-1122.e1. Epub 2008 Feb 20.

PMID:
18082886

Supplemental Content

Support Center